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Purpose: To study the effect of chitosan molecular weight on the physicochemical and antibacterial 
properties of silver-chitosan nanoparticles. 
Methods:  A series of silver-chitosan nanoparticles of different sizes were produced using various 
molecular weight (MW) grades of chitosan by an aqueous chemical reduction method. The 
nanoparticles were characterized by ultraviolet-visible absorption spectroscopy (UV-Vis), scanning 
electron microscopy (SEM), differential scanning calorimetry (DSC), dynamic light scattering (DLS) and 
laser Doppler electrophoresis (LDE). The antibacterial properties of the nanoparticles were also 
evaluated by agar diffusion method. 
Results: The size of the silver-chitosan nanoparticles, ranging from 21.9 to 175.3 nm, was influenced by 
chitosan MW as well as by other process conditions. Although, the nanoparticles were not stable in 
liquid form, they however showed good stability in the solid state due to their low zeta potential. SEM 
images indicate that the nanoparticles were spherical. The antibacterial activity of the nanoparticles 
against Staphylococcus aureus increased with decrease in particle size owing to increase in surface 
area. The smallest particle size (21.9 nm) was obtained by using high chitosan MW at 4 °C and a 
stirring speed of 800 rpm. 
Conclusion:  Chitosan is an effective agent for the preparation of silver nanoparticles. The size of the 
nanoparticles can be modulated by varying both chitosan MW and process conditions such as 
temperature and stirring speed. 
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INTRODUCTION 
 
The antibacterial effects of silver (Ag) salts 
have been known for over 2000 years, but 
they have only been in common use as an 
antimicrobial since the 19
th
 century [1]. Ag is 
currently used to control bacterial growth in a 
variety of applications, including dental work, 
catheters, and burn wounds [1]. Silver nitrate 
solution causes argyria (staining of the skin) 
and a burning sensation on application. Ag 
ions and Ag-based compounds are highly 
toxic to microorganisms. They show strong 
biocidal activity against as many as 12 
species of bacteria including E. coli [2]. 
Today, other forms of silver are available 
which do not have the disadvantages of 
earlier solutions.  
 
Modern dressings are capable of delivering 
silver through a sustained-release 
mechanism. This helps to avoid toxicity and 
yet ensures delivery of a therapeutic dose of 
silver to the wound [3]. It has been shown 
that reducing the particle size of materials is 
an efficient and reliable tool for improving 
their actions; hence, silver nanoparticles in 
some modern dressings, such as Acticoat
®
, 
aids in burns management [4]. The 
antimicrobial properties of silver-containing 
wound dressings have been studied by a 
microcalorimetric technique. The results 
showed that this kind of dressing has the 
capacity to kill common wound pathogens - 
Staphylococcus aureus and Pseudomonas 
aeruginosa [5]. Different nano silver-coated 
barrier dressings were reported to exhibit 
antimicrobial activity and reduce infection in 
wounds [6].  The antibacterial activity of 
chitosan tripolyphosphate nanoparticles 
loaded with various metal ions was 
investigated by Du et al and the results 
showed that antibacterial activity was 
enhanced by the loaded metal ions [7]. An 
earlier work showed that accumulation of 
silver nanoparticles in bacterial membrane 
caused a significant increase in membrane 
permeability, resulting in the death of the cell 
[8].  
 
Silver nanoparticles have been produced by 
different methods, one of which is the 
chemical reaction method [9]. In this method, 
Ag ions are reduced by UV or γ- irradiation, 
ultrasound, prolonged reflux, or chemicals to 
produce silver nanoparticles [10]. Two other 
methods used include nanoparticle colloid 
[11] and organic-inorganic composition film 
[12]. Hybridation of Ag nanoparticles with 
amphiphilic hyperbranched macromolecules 
has been shown to exhibit good antimicrobial 
properties [13].  
 
Chitosan is the N-deacetylated derivative of 
chitin. The positive charge of chitosan affords 
the polymer numerous and unique 
physiological and biological properties. 
Several studies have demonstrated the effect 
of molecular weight and concentration of 
chitosan on antibacterial and antifungal 
activities [14].  The aim of this work was to 
formulate and evaluate the antibacterial 
activity of simple and cost-effective silver-
chitosan nanocomposite formulations made 
with different molecular weight grades of 






Low, medium and high molecular weight 
(MW) grades of chitosan with MW of 100, 
400 and 600 KD, respectively, were 
purchased from Fluka BioChemica, Japan. 
Their degree of deacetylation was 85 %. 
Silver nitrate (AgNO3) and sodium 
borohydride (NaBH4) were purchased from 
Merck, Germany. 
 
Preparation of silver-chitosan nano-
composites 
 
A solution of chitosan (1 - 3 mg/ml) in acetic 
acid solution (1 - 2 %) was first prepared. 
Due to the poor solubility of chitosan, the 
mixture was vortexed to achieve complete 
dissolution, and then kept overnight at room 
temperature. The solution was filtered 
through a 0.22 µm millipore syringe filter to 
remove any impurity before use. Silver-
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chitosan nanocomposites were obtained by 
chemical reduction of the silver salt to yield 
the corresponding zero valent silver 
nanoparticles with NaBH4. To ensure 
complete reduction, the concentration of 
NaBH4 was 10 times that of the silver salt. 
Table 1 shows the composition of the various 
formulations prepared and the process 
conditions. The silver nanoparticles were 
separated by centrifugation at 15000 rpm and 
dried at 60 ºC for 24 h on a Petri dish, 
yielding a thin layer. 
 
Characterization of nanoparticles 
 
Scanning electron microscope (model 2360, 
Leo Oxford, England) was used to evaluate 
the surface and shape characteristics of the 
particles after prior coating with gold. 
 
UV-Vis absorption spectra of the samples 
were recorded in the wavelength range of 
300 to 500 nm with Genesys 2 
spectrophotometer, while size, polydispersity 
and zeta potential of the particles were 
determined using Zetasizer 3600 (Malvern 
Instruments, UK) at 25 °C and scattering 
angle of 90°. Differential scanning 
calorimetric studies (Perkin Elmer, Pyris 6, 
Germany) on the nanoparticles were carried 
out with the sample (≈10 mg) placed in a 
conventional aluminium pan with aluminium 
lid and heated from 50 to 250 °C at a rate of 
10 °C/min under a nitrogen atmosphere. An 
empty, loosely covered aluminium pan 




The antibacterial activity of the nanoparticles 
was evaluated against Staphylococcus 
aureus (PTCC 1112) by the agar diffusion 
method with soybean-casein digest agar 
(SCDA) as the medium. An aliquot of silver-
nanoparticle dispersion (50 µl) was added 
into each of six wells in a plate, and then 
incubated for 24 h at 40 °C. Antibacterial 
activity was measured, in triplicate, as the 
diameter of the inhibitory zones in the plates; 
the mean of three measurements was taken. 
Gentamicin solution (50 µl, 1 mg/ml) was 
used as reference standard. Control 
experiments with polymers and solvents were 
carried out and the control inhibitory zone 
was subtracted from inhibitory zone for the 
test sample to arrive at the actual value of the 




The results were expressed as mean ± 
standard deviation (SD). Student’s t-test and 
one-way analysis of variance (ANOVA) were 
applied to ascertain significant differences in 
antibacterial activity and particle size for 
various formulations using Sigma Stat 
software, version 2. Differences were 
considered to be statistically significant at p < 
0.05.   
 
RESULTS   
 
Size and zeta potential of nanoparticles  
 
Table 1 shows, amongst others the particle size 
of the formulations. It indicates that the size of 
silver nanoparticles depends on various 
process factors including chitosan MW, 
temperature, zeta potential and stirring rate. 
Alteration of these process variables had a 
major effect on the size of the nanoparticles.    
 
In terms of chitosan molecular weight (MW), the 
rank order of particle size was medium MW > 
low MW > high MW. Nanoparticle size 
decreased significantly with increase in stirrer 
speed and also as temperature decreased from 
25 to 4 °C (p < 0.05). The smallest size (21.9 
nm) was achieved for F18 when high MW 
chitosan was used at 4 °C and 800 rev/min.  
 
All the formulations showed low zeta potential 
(Table 1) and significant variation in particle 
size after storage at 4, 25 or 45 °C for 10 days 
in dispersion form (p < 0.05). There was a 
direct correlation between particle size and 
temperature of preparation. Although the 
nanoparticles showed aggregation and 
physical instability in liquid form, leading to 
the formation of larger particles, they 
nevertheless exhibited good physical stability 
in the solid state. 
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F1 L 2 20 400 25 1 70±5 0.042 -0.59 
F2 M 2 20 400 25 1 76±4 0.031 0.01 
F3 H 2 20 400 25 1 26±2 0.030 -4.17 
F4 L 2 20 400 4 1 30±3 0.026 -4.25 
F5 M 2 20 400 4 1 66±4 0.057 -5.86 
F6 H 2 20 400 4 1 24±3 0.065 -4.37 
F7 L 2 40 400 25 1 80±5 0.061 0.89 
F8 M 2 40 400 25 1 97±6 0.049 1.77 
F9 H 2 40 400 25 1 31±2 0.036 -5.70 
F10 L 3 20 400 25 1 142±3 0.086 7.44 
F11 M 3 20 400 25 1 134±4 0.047 6.19 
F12 H 3 20 400 25 1 102±4 0.060 2.86 
F13 L 2 20 400 25 2 114±4 0.057 4.89 
F14 M 2 20 400 25 2 175±3 0.062 3.72 
F15 H 2 20 400 25 2 102±3 0.035 9.10 
F16 L 2 20 800 4 1 25±2 0.036 -5.51 
F17 M 2 20 800 4 1 35±2 0.049 -5.13 
F18 H 2 20 800 4 1 21 ±1 0.037 -7.33 
L, M and H = low, medium and high MW chitosan, respectively; SR = stirring rate (rev/min); ZP = zeta potential; PDI = 




Fig 1 shows the UV-Vis spectra of the silver-
chitosan nanocomposites. All the spectra 
exhibited an absorption band at around 400 - 
420 nm, which is a typical plasmon band, 
suggesting the formation of silver 
nanoparticles. The width of the absorption 
band for the nanoparticles containing medium 
molecular weight chitosan is greater than 
those containing low and high molecular 
weight chitosan. Furthermore, the center of 
absorption band also varied slightly with 
chitosan molecular weight, a factor that 
operates as a controller of nucleation as well 




Figure 1: UV-Vis spectra of the silver-chitosan 
nanoparticles produced with low (A), medium (B) 
and high (C) molecular weight chitosan. 
Scanning electron microscopy (SEM)  
 
The results of SEM, shown in Fig 2, indicate 
that the silver-chitosan nanoparticles were 
spherical with particle size in the range of 20 




Figure 2: SEM photo of silver-chitosan 
nanoparticles (F12). 
 
Differential scanning calorimetry (DSC)  
 
Fig 3 indicates that the thermograms of the 
nanoparticles containing low, medium and 
high MW chitosan exhibited an endothermic 
peak below 100 ºC, which is probably related 
to water loss, and a slight exothermic 
transition above 200 ºC, which likely 
corresponds to chitosan decomposition.  
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Fig 3: DSC thermograms of silver-chitosan 
nanoparticles containing low (A), medium (B), 




Table 3 shows that the diameter of the zone 
of inhibition increased as the size of the 
particles decreased.  
 
Table 3: Antibacterial activity of some silver-
chitosan nanoparticles (mean±SD, n = 3) 
 












When AgNO3 was mixed with chitosan 
solution, Ag
+
 ions probably bound to chitosan 
macromolecules via electrostatic interaction 
between the electron–rich oxygen atoms of 
the polar hydroxyl and ether groups of 
chitosan and the electropositive transition 
cations (Ag
+
). However, a study of the 
mechanism of the reaction process of silver 
nitrate with chitosan by Wei et al using FTIR 
[17] also showed possible interaction 
between silver salts and chitosan molecules, 
which may account for the reduction of Ag 
ions and stabilization of silver-chitosan 
nanoparticles. Thus the attachment of silver 
to the nitrogen atoms in chitosan reduced the 
vibration intensity of the N-H bond due to 
increased molecule weight after silver 
binding. It has been shown that the stiffness 
and conformations of small molecular weight 
chitosan were greater and more extended, 
respectively, than higher molecular weight 
chitosan [18]. Furthermore, high molecular 
weight chitosan is more flexible [19]. 
Generally, high MW chitosan would be a 
more effective stabilizer for Ag-chitosan 
nanoparticles owing to its greater flexibility 
and viscosity than lower MW grades. Also, 
production of the nanoparticles at 4 °C would 
result in smaller particles than at 25 °C due 
probably to increase in medium viscosity. 
 
The inhibitory effect of silver on 
microorganisms tested is effected via two 
possible mechanisms First, is the 
electrostatic attraction between the negatively 
charged cell membrane of the 
microorganisms and the positively charged 
Ag, and second, is the formation of ‘pits’ in 
the cell wall of bacteria related to Ag 
concentration [20]. In this study, since the 
zero valent metal nanoparticles were 
obtained by chemical reduction of metal salts, 
it seems the latter mechanism would have 
been mooted. A previous study showed that 
25 nm diameter particles exhibited maximum 
antibacterial activity [18]; therefore, the 
method used in this study would be suitable 
for producing 25 nm silver-chitosan particles. 
The smaller the size of the nanoparticles the 
larger the surface area in contact with the 
bacterial cells and hence, the greater the 




Although chitosan has often been used as a 
stabilizer in silver nanoparticles production 
process, there is no report, to the best of our 
knowledge, about the effect of its MW in this 
process. This study shows that the size of 
silver nanoparticles can be controlled by 
varying chitosan MW as well as process 
conditions such as temperature and stirring 
speed. One of the most important properties 
of silver nanoparticles is their antimicrobial 
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property. This study demonstrates that the 
antimicrobial effect of silver nanoparticles 
strongly depends on their size. Smaller 
particles showed greater antimicrobial activity 
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